The present invention is directed to a methods for the stimulation of hair, lash and/or nail growth by the administration of extracellular matrix (ECM) and/or conditioned culture media (CCM) compositions in combination with active agents such as minoxidil and bimatoprost. The combination of hypoxic CCM and an active agent acts to promote hair, lash and/or nail growth and/or promote hair follicle development and/or activate or stimulate on an area of the skin when administered to the region of skin or tissue in need of growth or repair in a subject.

The present invention is directed to a methods for the stimulation of hair, lash and/or nail growth by the administration of extracellular matrix (ECM) and/or conditioned culture media (CCM) compositions in combination with active agents such as minoxidil and bimatoprost. The combination of hypoxic CCM and an active agent acts to promote hair, lash and/or nail growth and/or promote hair follicle development and/or activate or stimulate on an area of the skin when administered to the region of skin or tissue in need of growth or repair in a subject.

Compositions for the topical treatment of fungal infections in nails, comprising at least one physiologically acceptable carboxylic acid capable of reducing the pH in keratinous tissue, in particular nails, of a treated person below 4.0, preferably in the range of 1.5-4.0, a physiologically acceptable carrier comprising at least one C1-C4 alkyl ester of lactic acid, and at least one physiologically acceptable fluorescent whitening agent. The invention relates to the use of said composition for the preparation of a product suitable for treatment of fungal infections. The invention also relates to the use of said composition for the treatment of a fungal infection.

Cosmetic or pharmaceutical compositions are described herein for application to skin, hair and/or a nail of a subject, as well as methods utilizing same for administering hydrogen peroxide to skin, hair and/or a nail, and kits for applying same. The compositions comprise a hydrogen peroxide-producing enzyme, and a substrate of the hydrogen peroxide-producing enzyme. Further described herein are cosmetic compositions and kits for lightening skin and/or hair, which further comprise a lignin peroxidase, as well as cosmetic methods utilizing same.

Cosmetic or pharmaceutical compositions are described herein for application to skin, hair and/or a nail of a subject, as well as methods utilizing same for administering hydrogen peroxide to skin, hair and/or a nail, and kits for applying same. The compositions comprise a hydrogen peroxide-producing enzyme, and a substrate of the hydrogen peroxide-producing enzyme. Further described herein are cosmetic compositions and kits for lightening skin and/or hair, which further comprise a lignin peroxidase, as well as cosmetic methods utilizing same.

Described herein is a method of using, as perfuming ingredients, e.g. to impart odor notes of the fruity, fruity-exotic types, cyclopentanone compounds of formula

##STR00001##

in a form of any one of its stereoisomers or a mixture thereof, and wherein n represents 1 or 2.

Described herein is a method of using, as perfuming ingredients, e.g. to impart odor notes of the fruity, fruity-exotic types, cyclopentanone compounds of formula

##STR00001##

in a form of any one of its stereoisomers or a mixture thereof, and wherein n represents 1 or 2.

A dermal skin protectant and carrier comprising a combination of two different viscosity dimethicone components, wherein the difference between the two different viscosity dimethicone components is about 2.0 million cP or greater; and comprising at least one active ingredient.

A dermal skin protectant and carrier comprising a combination of two different viscosity dimethicone components, wherein the difference between the two different viscosity dimethicone components is about 2.0 million cP or greater; and comprising at least one active ingredient.

A dermal skin protectant and carrier comprising a combination of two different viscosity dimethicone components, wherein the difference between the two different viscosity dimethicone components is about 2.0 million cP or greater; and comprising at least one active ingredient.